Joerg Westermann
About
In The Last Decade
Joerg Westermann
5 papers receiving 333 citations
Peers
Comparison fields: 5 of 51
- Surgery 237
- Immunology 180
- Molecular Biology 89
- Small Animals 71
- Pulmonary and Respiratory Medicine 63
Countries citing papers authored by Joerg Westermann
This map shows the geographic impact of Joerg Westermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Westermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Westermann more than expected).
Fields of papers citing papers by Joerg Westermann
This network shows the impact of papers produced by Joerg Westermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Westermann. The network helps show where Joerg Westermann may publish in the future.
Co-authorship network of co-authors of Joerg Westermann
This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Westermann. A scholar is included among the top collaborators of Joerg Westermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Westermann. Joerg Westermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis. | 8 |
| 6 | Succesful long-term monotherapy with rituximab in a chemotherapy-refractory patient with chronic B-CLL: a case report | 0 |
| 7 | 264 | |
| 8 | Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. | 61 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.